Publication: Environment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA
Issued Date
2013-03-01
Resource Type
ISSN
10959157
08968411
08968411
Other identifier(s)
2-s2.0-84875923455
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Autoimmunity. Vol.41, (2013), 79-86
Suggested Citation
Patrick S.C. Leung, Jinjun Wang, Phornnop Naiyanetr, Thomas P. Kenny, Kit S. Lam, Mark J. Kurth, M. Eric Gershwin Environment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA. Journal of Autoimmunity. Vol.41, (2013), 79-86. doi:10.1016/j.jaut.2012.12.007 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/31956
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Environment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA
Other Contributor(s)
Abstract
Environmental stimulation is a major factor in the initiation and perpetuation of autoimmune diseases. We have addressed this issue and focused on primary biliary cirrhosis (PBC), an autoimmune disease of the liver. Immunologically, PBC is distinguished by immune mediated destruction of the intra hepatic bile ducts and the presence of high titer antimitochondrial autoantibodies (AMA) directed against a highly specific epitope within the lipoic acid binding domain of the pyruvate dehydrogenase E2 subunit (PDC-E2). We submit that the uniqueness of AMA epitope specificity and the conformational changes of the PDC-E2 lipoyl domain during physiological acyl transfer could be the lynchpin to the etiology of PBC and postulate that chemical xenobiotics modification of the lipoyl domain of PDC-E2 is sufficient to break self-tolerance, with subsequent production of AMA in patients with PBC. Indeed, using quantitative structure activity relationship (QSAR) analysis on a peptide-xenobiotic conjugate microarray platform, we have demonstrated that when the lipoyl domain of PDC-E2 was modified with specific synthetic small molecule lipoyl mimics, the ensuing structures displayed highly specific reactivity to PBC sera, at levels often higher than the native PDC-E2 molecule. Hereby, we discuss our recent QSAR analysis data on specific AMA reactivity against a focused panel of lipoic acid mimic in which the lipoyl di-sulfide bond are modified. Furthermore, data on the immunological characterization of antigen and Ig isotype specificities against one such lipoic acid mimic; 6,8-bis(acetylthio)octanoic acid (SAc), when compared with rPDC-E2, strongly support a xenobiotic etiology in PBC. This observation is of particular significance in that approximately one third of patients who have taken excessive acetaminophen (APAP) developed AMA with same specificity as patients with PBC, suggesting that the lipoic domain are a target of APAP electrophilic metabolites such as NAPQI. We submit that in genetically susceptible hosts, electrophilic modification of lipoic acid in PDC-E2 by acetaminophen or similar drugs can facilitate loss of tolerance and lead to the development of PBC. © 2012 Elsevier Ltd.